Entry |
|
Name |
Gefapixant (USAN/INN) |
Formula |
C14H19N5O4S
|
Exact mass |
353.1158
|
Mol weight |
353.40
|
Structure |

|
Class |
Unclassified
DG03292 Purinergic receptor P2X 3 antagonist
|
Remark |
Product (DG03083): | D11693<JP> |
|
Efficacy |
Analgesic, Anti-inflammatory, Antitussive, P2X3 receptor antagonist |
Comment |
Treatment of inflammatory, visceral, neuropathic and cancer pain and respiratory symptoms, including cough
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R05 COUGH AND COLD PREPARATIONS
R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS
R05DB Other cough suppressants
R05DB29 Gefapixant
D11349 Gefapixant (USAN/INN)
Drug groups [BR:br08330]
Unclassified
DG03292 Purinergic receptor P2X 3 antagonist
DG03083 Gefapixant
D11349 Gefapixant
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
ATP-gated cation channel (P2X)
P2RX3
D11349 Gefapixant (USAN/INN)
Drug groups [BR:br08330]
Unclassified
DG03292 Purinergic receptor P2X 3 antagonist
DG03083 Gefapixant
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 24
1 C8x C 15.8900 -17.9900
2 C8y C 15.8900 -19.3900
3 C8y C 14.7000 -20.0900
4 C8x C 13.4400 -19.3900
5 C8y C 13.4400 -17.9900
6 C8y C 14.7000 -17.2900
7 O2a O 17.0800 -20.0900
8 C8y C 18.2700 -19.3900
9 C8x C 18.2700 -17.9900
10 N5x N 19.5300 -17.2900
11 C8y C 20.7200 -17.9900
12 N5x N 20.7200 -19.3900
13 C8y C 19.5300 -20.0900
14 N1a N 21.9100 -17.2900
15 S4a S 14.7000 -15.8900
16 O2a O 12.2500 -17.2900
17 C1a C 11.0600 -17.9900
18 C1c C 14.7000 -21.4900
19 C1a C 15.8900 -22.1900
20 C1a C 13.5100 -22.1900
21 O3c O 13.3000 -15.8900
22 O3c O 16.1000 -15.8900
23 N1a N 14.7000 -14.4900
24 N1a N 19.5472 -21.4899
BOND 25
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 11 14 1
16 6 15 1
17 5 16 1
18 16 17 1
19 3 18 1
20 18 19 1
21 18 20 1
22 15 21 2
23 15 22 2
24 15 23 1
25 13 24 1
|